Skip to content
Menu

Head-to-head comparison

AHBARx vs Next Vial

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Ranked #122Desk pick
AHBARx

AHBARx puts both molecules and all three supply tiers on the product page before any questionnaire, and itemizes the consultation and shipping inside the figure rather than adding them at checkout.

From $249/mo sema · From $349/mo tirz · Verified September 2026

Marked down on: The terms and privacy policy are an unfilled template, with pharmacies, labs and even the site's own address left as bracketed placeholders.

vs
Ranked #290
Next Vial

Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options.

$250/mo sema · Verified July 2026

Marked down on: Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)

AHBARx takes this head-to-head with the higher Desk Score, 75/100 (C) against 64/100 (C) for Next Vial. Next Vial still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

AHBARx

75/100

C

Overall

Next Vial

64/100

C

Price transparency

78
30

State access

86
78

Molecule range

66
66

Onboarding speed

70
78

Support responsiveness

71
72

Licensing & trust

69
86

The spec sheet

FieldAHBARxNext Vial
SemaglutideFrom $249/moFrom $249/mo (compounded)$250/mo$250/mo (compounded)
TirzepatideFrom $349/moFrom $349/mo (compounded)Not listed on Next Vial's site (checked July 2026)
CoverageAll 50 states and D.C.49 states
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forAnyone who wants the consultation and shipping costs settled before they hand over an email address.People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner.
Desk Score75/100C64/100C

The verdict

Desk pick — AHBARx

AHBARx takes this head-to-head with the higher Desk Score, 75/100 (C) against 64/100 (C) for Next Vial. Next Vial still holds its ground where its strengths line up with yours.

Choose AHBARx if…

Anyone who wants the consultation and shipping costs settled before they hand over an email address.

From $249/mo sema · From $349/mo tirz · All 50 states and D.C.

Choose Next Vial if…

People seeking compounded GLP-1 care with LegitScript certification and a named pharmacy partner.

$250/mo sema · 49 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: AHBARx · Next Vial.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.